A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors

This study is testing a personalized T-cell therapy — immune cells that are grown in a lab and trained to recognize your specific tumor's unique markers — in people with advanced solid tumors like ovarian cancer, lung cancer, or colon cancer. **You may be eligible if...** - You are between 18 and 75 years old - You have a solid tumor (such as ovarian cancer, non-small cell lung cancer, or colorectal cancer) confirmed by biopsy or lab test - Standard cancer treatments have failed or you have declined further chemotherapy - Your expected survival is more than 3 months - Your general health is reasonably good (ECOG score 0–2) - You are willing and able to use contraception during the study if you are of childbearing age **You may NOT be eligible if...** - You have received any form of immunotherapy in the past 3 months - You have serious infections, autoimmune disease, or significant organ problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.